Title : Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancer.

Pub. Date : 2004 Mar-Apr

PMID : 15161043






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancer. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Considering the high impact of progression-free survival and duration of response as outcome parameters, the sHER-2/neu status is a predictive indicator for benefit from paclitaxel chemotherapy. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens